The effect of aprotinin on hypoxia-reoxygenation-induced changes in neutrophil and endothelial function

European Journal of Anaesthesiology

Volumn 21, Issue 12, 2004, Pages 973-979

  Harmon, Dominic ^a   Lan, W ^a   Shorten, G ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Aprotinin; Endothilium; Hypoxia ischaemia, brain; Neutrophil

Indexed keywords

APROTININ; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA;

ANTIGEN EXPRESSION; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL FUNCTION; CELL HYPOXIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; HEART SURGERY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NEUROPROTECTION; NEUTROPHIL; PROTEIN EXPRESSION; REOXYGENATION; REPERFUSION INJURY; UPREGULATION;

ANALYSIS OF VARIANCE; APROTININ; BRAIN ISCHEMIA; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMOSTATICS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; NEUTROPHILS; REFERENCE VALUES; REPERFUSION; REPERFUSION INJURY; TIME FACTORS; UMBILICAL VEINS;

EID: 14244264138     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-200412000-00008     Document Type: Article

References (37)

1. Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial J Thorac Cardiovasc Surg 1998; 116: 716-730.
2. Murkin JM. Attenuation of neurologic injury during cardiac surgery. Ann Thorac Sarg 2001; 72: S1838-S1844.
3. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232-244.
4. del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland Br, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 22: 1276-1283.
5. Mori E, del Zoppo GJ, Chambers D, et al. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992; 23: 712-718.
6. Jansen P, Baufreton C, Besnerais P, et al. Heparin coated circuits and aprotinin prime for coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 1363-1366.
7. Lord RA, Roath OS, Thompson JF, Chant AD, Francis JL. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg 1992; 79: 517-521.
8. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993; 106: 1-10.
9. Asimakopoulos G, Lidington EA, Mason J, O'Haskard D, Taylor KM, Landis RC. Effect of aprotinin on endothelial activation. J Thorac Cardiovasc Surg 2001; 122: 123-128.
10. Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg 1994; 58: 146-153.
11. Kamiya T, Katayama Y, Kashiwagi F, Terashi A. The role of bradykinin in mediating ischaemic brain edema in rats. Stroke 1993; 24: 571-576.
12. Gurevitch J, Barak J, Hochhauser E, Paz Y, Yakirevich V. Aprotinin improves myocardial recovery after ischemia and reperfusion. Effects of the drug on isolated rat hearts. J Thorac Cardiovac Surg 1994; 108: 109-118.
13. Carlos TM, Harlan JM. Leukocyte-endothelial cell adhesion molecules. Blood 1994; 84: 2068-2101.
14. Scannell G, Waxman K, Vazira ND, et al. Hypoxia-induced alterations of neutrophil membrane receptors. J Surg Res 1995; 59: 141-145.
15. Mataki H, Inagaki T, Yokoyama M, Maeda S. ICAM-1 expression and cellular injury in cultured endothelial cells under hypoxia/reoxygenation. Kobe J Med Sci 1994; 40: 49-63.
16. Clark ET, Desai TR, Hynes KL, Gewertz BL. Endothelial cell response to hypoxia-reoxygenation is mediated by IL-1. J Surg Res 1995; 58: 675-681.
17. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1A. An autocrine mechanism promoting expression of leukocyte adhesion molecules on vessel surface. J Clin Invest 1992; 90: 2333-2339.
18. Asimakopoulos G, Thompson R, Nourshargh S, et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg 2000; 120: 361-369.
19. Sethi S, Singh MP, Dikshit M. Nitric oxide mediated augmentation of polmorphonuclear free radical generation following hypoxia-reoxygenation. Blood 1999: 93; 333-340.
20. Wellicome SM, Thornhill MH, Pitzalis C, et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 1990; 144: 2558-2565.
21. Wang X, Feuerstein GZ. Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma 1995; 12: 825-832.
22. Zhang W, Smith C, Hewlett C, Stanimirovic D. Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1β. J Cereb Blood Flow Metab 2000; 20: 967-978.
23. Lahat N, Zlotnick AY, Shtiller R, Bar J, Merin G. Serum levels of IL-1, IL-6 and tumor necrosis factor in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89: 255-260.
24. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effects of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105: 25-30.
25. Fujiwara T, Seo N, Murayama T, Hirata S, Kawahito K, Kawakami M. Transient rise in serum cytokines during coronary artery bypass graft surgery. Eur Cytokine Netw 1997; 8: 61-66.
26. Cole DJ, Patel PM, Schell RM, Drummond JC, Osborne TN. Brain ecosanoid levels during temporal focal cerebral ischaemia in rats: a microdialysis scudy. J Neurosurg Anesthesiol 1993; 5: 41-47.
27. Kontos MA. Oxygen radicals in cerebral ischaemia. In: Ginsberg MD, Dietrich WD, eds. Cerebovascular Diseases: 16th Princeton Conference. New York: Raven Press, 1989: 365-372.
28. Ames A, Wright L, Masayoshi K, Thurston J, Majino G. Cerebral ischemia: The no-reflow phenomenon. Am J Pathol 1968; 52: 437-443.
29. Jean W, Spellman SR, Nussbaum ES, Low WC. Reperfusion injury after focal ischaemia: the role of inflammation and the therapeutic horizon. Neurosurgery 1998; 43: 1382-1396.
30. Pruefer D, Makowski J, Dahm M, et al. Aprotinin inhibits leukocyte-endothelial cell interactions after hemorrhage and reperfusion. Ann Thorac Surg 2003; 75: 210-215.
31. Sunamori M, Sultan I, Suzuki A. Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion. Ann Thorac Surg 1991; 52: 971-978.
32. Scannell G. Leukocyte responses to hypoxic/ischemic conditions. New Horiz 1996; 4: 179-183.
33. -) in microsomes of pulmonary vascular smooth muscle. Biochem J 1996; 317: 885-890.
34. Nagahiro I, White T, Yano M, et al. Recombinant Kunitz protease inhibitor ameliorates reperfusion injury in rat lung transplantation. Ann Thorac Surg 1998; 65: 66-69.
35. 2) and hydroxyl radical production by human polymorphonuclear leukocytes. Hepato-gastroenterology 1992; 39: 59-61.
36. Fearon DT, Collins LA. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 1983; 130: 370-375.
37. Barry MC, Wang JH, Kelly CJ, et al. Plasma factors augment neutrophil and endothelial cell activation during aortic surgery. Eur J Vasc Endovasc Surg 1997; 13: 381-387.